Uma condição neurológica tipicamente marcada por reações de susto muito fortes ao toque ou a sons, e rigidez muscular.
Introdução
O que você precisa saber de cara
Uma condição neurológica tipicamente marcada por reações de susto muito fortes ao toque ou a sons, e rigidez muscular.
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 23 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 65 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
6 genes identificados com associação a esta condição.
Subunit of heteromeric glycine-gated chloride channels (PubMed:11929858, PubMed:15302677, PubMed:16144831, PubMed:22715885, PubMed:23238346, PubMed:25445488, PubMed:34473954, PubMed:8717357). Plays an important role in the down-regulation of neuronal excitability (PubMed:11929858, PubMed:23238346). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488)
Postsynaptic cell membraneSynapseCell projection, dendriteCell membraneCytoplasm
Hyperekplexia 2
A neurologic disorder characterized by muscular rigidity of central nervous system origin, particularly in the neonatal period, and by an exaggerated startle response to unexpected acoustic or tactile stimuli.
Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940) Also has a catalytic activity and catalyzes two steps in the biosynthesis of the molybdenum cofactor. In the first step, molybdopterin is adenylated. Subsequently,
Postsynaptic cell membraneCell membraneCytoplasm, cytosolCytoplasm, cytoskeletonCell projection, dendritePostsynaptic density
Molybdenum cofactor deficiency C
A form of molybdenum cofactor deficiency, an autosomal recessive metabolic disorder leading to the pleiotropic loss of molybdoenzyme activities. It is clinically characterized by onset in infancy of poor feeding, intractable seizures, severe psychomotor retardation, and death in early childhood in most patients.
Subunit of heteromeric glycine-gated chloride channels (PubMed:14551753, PubMed:23994010, PubMed:25730860, PubMed:37821459). Plays an important role in the down-regulation of neuronal excitability (PubMed:8298642, PubMed:9009272). Contributes to the generation of inhibitory postsynaptic currents (PubMed:25445488). Channel activity is potentiated by ethanol (PubMed:25973519). Potentiation of channel activity by intoxicating levels of ethanol contribute to the sedative effects of ethanol (By simil
Postsynaptic cell membraneSynapsePerikaryonCell projection, dendriteCell membrane
Hyperekplexia 1
A neurologic disorder characterized by muscular rigidity of central nervous system origin, particularly in the neonatal period, and by an exaggerated startle response to unexpected acoustic or tactile stimuli.
Outer mitochondrial translocase required to remove mislocalized tail-anchored transmembrane proteins on mitochondria (PubMed:24843043). Specifically recognizes and binds tail-anchored transmembrane proteins: acts as a dislocase that mediates the ATP-dependent extraction of mistargeted tail-anchored transmembrane proteins from the mitochondrion outer membrane (By similarity). Also plays a critical role in regulating the surface expression of AMPA receptors (AMPAR), thereby regulating synaptic pla
Mitochondrion outer membranePeroxisome membranePostsynaptic cell membrane
Hyperekplexia 4
An autosomal recessive severe neurologic disorder apparent from birth. HKPX4 is characterized by little if any development, hypertonia, early-onset refractory seizures in some patients, and respiratory failure resulting in early death, mostly in the first months of life.
Sodium- and chloride-dependent glycine transporter (PubMed:10381548, PubMed:10606742, PubMed:16751771, PubMed:31370103, PubMed:9845349). Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals (PubMed:9845349). May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses (PubMed:9845349) Lacks sodium- and chloride-dependent glycine transporter activity Lacks sodium- and chloride-dependent glycine trans
Cell membrane
Hyperekplexia 3
A neurologic disorder characterized by neonatal hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. Notably, in some cases, symptoms resolved in the first year of life.
Acts as a guanine nucleotide exchange factor (GEF) for CDC42. Promotes formation of GPHN clusters (By similarity)
CytoplasmPostsynaptic density
Developmental and epileptic encephalopathy 8
A disorder characterized by hyperekplexia and early infantile epileptic encephalopathy. Neurologic features include exaggerated startle response, seizures, impaired psychomotor development, and intellectual disability. Seizures can be provoked by tactile stimulation or extreme emotion.
Variantes genéticas (ClinVar)
538 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 1,713 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
10 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Hiperecplexia
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
4 ensaios clínicos encontrados, 1 ativos.
Publicações mais relevantes
A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene.
Hyperekplexia is a rare hereditary neurological disorder characterized by an exaggerated startle response and generalized rigidity. It is frequently misdiagnosed as epilepsy, leading to unnecessary treatment. We report a case of mild hyperekplexia caused by a novel GLRA1 mutation, highlighting the diagnostic value of genetic testing in atypical presentations. An 18-month-old girl presented with recurrent episodes of vacant staring and limb rigidity triggered by sudden sounds or tactile stimuli over the past 2 months. She had a history of 3 febrile seizures but normal development. Physical examination revealed hypersensitivity to external stimuli, but the nose-tap test was negative. Routine metabolic studies, brain magnetic resonance imaging, and electroencephalogram were normal. Whole-exome sequencing identified a de novo heterozygous nonsense variant c.593G > A (p.Trp198Ter) in the GLRA1 gene, confirming the diagnosis of hyperekplexia. Given the confirmed diagnosis and the mild nature of the symptoms, the previously prescribed antiepileptic drug (levetiracetam) was discontinued. Clonazepam was not initiated due to the mild severity of the condition. At the 8-month follow-up, the patient remained seizure-free with minimal non-epileptic stimulus-induced symptoms. Her growth and psychomotor development were normal. This case expands the phenotypic spectrum of GLRA1-related hyperekplexia to include mild phenotypes with a negative nose-tap test. It underscores the critical role of whole-exome sequencing in distinguishing hyperekplexia from epilepsy, thereby avoiding inappropriate antiepileptic therapy. Asparagine synthetase deficiency (ASD) mainly presents as a triad of congenital microcephaly, severe developmental delay, and axial hypotonia followed by spastic quadriplegia. Low cerebrospinal fluid asparagine concentration can help the clinician in differentiating this disorder from others. In most individuals with ASD, apnea, excessive irritability, and seizures occur soon after birth. Affected individuals typically do not acquire any developmental milestones. Spastic quadriplegia can lead to severe contractures of the limbs and neurogenic scoliosis. Feeding difficulties (gastroesophageal reflux disease, frequent vomiting, swallowing dysfunction, and gastroesophageal incoordination) are a significant problem in most affected individuals. A majority have cortical blindness. Brain MRI findings are nonspecific but may include generalized atrophy and simplified gyral pattern. The diagnosis of ASD is established in a proband with suggestive findings and biallelic pathogenic variants in ASNS identified by molecular genetic testing. Treatment of manifestations: Supportive developmental therapies; standard treatment for seizures; antispastic medication (baclofen, tizanidine) and/or Botox® injection for spasticity; clonazepam for hyperekplexia; treatment of scoliosis per orthopedist; feeding therapy and/or nasogastric or gastrostomy tube to support nutrition; pharmacologic treatment for gastroesophageal reflux disease; standard treatment for constipation; low vision services as needed; mechanical ventilation may be required for apnea; regular immunizations to prevent life-threatening infections; hearing aids as needed for hearing loss; transitional plan to adult care; social work and family support. Surveillance: At each visit, evaluation of developmental progress and growth; assessment for progression of spasticity and contractures; assessment for new neurologic manifestations; physical medicine and occupational and physical therapy assessment of mobility and self-help skills; assessment for scoliosis; measurement of growth parameters; assessment of nutritional status and safety of oral intake; assessment for constipation; and assessment for evidence of aspiration and respiratory insufficiency. Measurement of serum total protein, albumin, and prealbumin every six months. Annual ophthalmologic evaluation. EEG if there are concerns for new-onset seizure activity or progression of seizures. Audiologic evaluation if there are concerns for hearing loss. ASD is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for an ASNS pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the ASNS pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing are possible.
A Novel Variant in GLRA1 Associated With Emotional Stimulus-Sensitive Hemichoreic Movements.
We present the case of a 61-year-old woman with late-onset hyperkinetic movement disorder, characterized by involuntary, choreiform movements predominantly affecting the right limbs. Symptoms began at age 60 and were exacerbated by emotional stress. Neurological and neurocognitive evaluations were unremarkable, and extensive diagnostic workup, including Magnetic Resonance Imaging (MRI), Electroencephalogram (EEG), Positron Emission Tomography with Fluorodeoxyglucose (FDG-PET) and genetic testing for common movement disorders, was largely negative. Notably, a heterozygous pathogenic variant (c.736C>T; p.Arg246Trp) in the GLRA1 gene was identified via exome sequencing. This gene encodes a glycine receptor subunit associated with Hyperekplexia (HPX), a rare neurometabolic disorder typically presenting in infancy with exaggerated startle responses. Although our patient did not show a classic HPX phenotype, the clinical picture included emotionally triggered motor symptoms and a positive response to clonazepam, a hallmark of HPX treatment. Clonazepam monotherapy at low doses led to sustained symptom control, while other treatments were less effective. Family history revealed similar late-onset symptoms in the patient's father, though undocumented. This case expands the phenotypic spectrum of HPX and suggests that atypical presentations may be misclassified as functional neurological disorders. It underscores the importance of genetic evaluation in unexplained adult-onset movement disorders and raises the possibility of underrecognized late-onset HPX variants in clinical practice.
A New GlyT2 Variant Associated with Hyperekplexia.
Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene (SLC6A5) cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes GLRA1 and GLRB did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber.
Motor phenotyping in a Greek cohort of patients with neonatal and infantile onset developmental and epileptic encephalopathy.
Developmental and epileptic encephalopathy (DEE) includes diseases where there is developmental impairment related to both the underlying etiology independent of epileptiform activity and the epileptic encephalopathy. Patients often present with movement disorders (MD). This study aims to delineate the motor phenotype in a cohort of patients with DEE. Retrospective review of 82 patients with DEE. MD type and distribution were documented and when available, video recordings were reviewed. Patients were classified into five etiological groups: 30.5 % had a likely genetic diagnosis, 29.3 % a confirmed genetic diagnosis, 18.3 % an inborn error of metabolism (IEM), 14.6 % an acquired brain lesion, and 7.3 % a brain dysplasia. Hyperkinetic MDs were present in 85.4 % of patients, including dystonia (48.8 %), stereotypies (22.0 %), chorea (20.7 %), hyperekplexia (15.9 %), tremor (14.6 %), and myoclonus (6.1 %). Parkinsonism was observed in 11 % of patients, ataxia in 8.5 % and multiple MDs in 50 %. Paroxysmal episodes of MD exacerbation occurred in 6 patients, and transient MD in 8. Dystonia was most frequent in patients with acquired brain lesions (p = 0.003). Parkinsonism was more frequent in patients with brain dysplasias and IEM (p = 0.043). This study confirms the high frequency of hyperkinetic and combined MD in DEE, and identifies characteristic MDs in conditions such SCN8A, FOXG1 and ARX related DEE, as well as ataxia and tremor in STXBP1, SCN1A, MTRFR, KCTD7 and 15q111-13 deletion. Novel observations, include the occurrence of paroxysmal dyskinetic exacerbations in FOXG1, axial stereotypies in KCNQ2, hyperekplexia in cortical dysplasia and Parkinsonism in ECHS1 with DEE.
Rafiq Syndrome: Old Variant in MAN1B1 Gene and Some New Phenotypic Features.
Rafiq syndrome is a congenital disorder of glycosylation type II that develops due to mutations in the Mannosidase Alpha Class 1B Member 1 (MAN1B1) gene encoding α 1,2-mannosidase. In the literature, 45 patients have been reported to date. This study presents a patient with some phenotypic traits that differ from previously reported patients with Rafiq syndrome.Since the patient was not diagnosed despite detailed examinations, whole exome sequencing was performed. The patientss' homozygous c.1000 C>T (p.Arg334Cys) pathogenic variant was detected in the MAN1B1 gene (NM_016219.5), which was consistent with Rafiq syndrome. Our patient's clinical findings were mainly similar to those of previously reported patients. However, our patient had feeding difficulty that started to improve after the fifth month and persistent hyperekplexia . Feeding difficulty and hyperekplexia concomitant to MAN1B1 gene mutation are reported for the first time. More extensive case series are needed to understand whether these findings are part of the syndrome or incidental comorbid conditions.
Publicações recentes
Role of the Glycine Transporter GlyT2 in the Neuronal Differentiation of PC12 Cells.
A dual manifestation of GAD-antibody spectrum disorder: a case of progressive encephalomyelitis with rigidity, myoclonus and autoimmune epilepsy with mesial temporal sclerosis.
A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene.
Asparagine Synthetase Deficiency.
Clinical features of progressive encephalomyelitis with rigidity and myoclonus: Case Report.
📚 EuropePMC247 artigos no totalmostrando 196
A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene.
MedicineClinical features of progressive encephalomyelitis with rigidity and myoclonus: Case Report.
Frontiers in immunologyA Novel Variant in GLRA1 Associated With Emotional Stimulus-Sensitive Hemichoreic Movements.
American journal of medical genetics. Part AA fatal infantile case with suspected hyperekplexia.
The journal of medical investigation : JMIHereditary Hyperekplexia Presenting with Muscle Stiffness, Seizures and Recurrent Apneas in An Infant.
Indian journal of pediatricsFamilial Hyperekplexia Caused by a Novel Homozygous SLC6A5 Variant: A Case Report.
Molecular syndromologyDeciphering the molecular mechanisms of startle disease: The role of the Asn46Lys mutation in the glycine receptor.
The Journal of chemical physicsA New GlyT2 Variant Associated with Hyperekplexia.
International journal of molecular sciencesA novel GLRB mutation in neonatal hyperekplexia with divergent EEG findings: a case series.
Annals of medicine and surgery (2012)Progressive encephalomyelitis with rigidity and myoclonus after thymectomy in a woman with myasthenia gravis.
Frontiers in immunologyGlycine receptors: Structure, function, and therapeutic implications.
Molecular aspects of medicineSTARDEV Study: Neurodevelopmental Trajectory and Long-Term Outcomes of Patients with Startle Disease/Hyperekplexia.
Movement disorders clinical practiceThe implications of hyperekplexia on children's quality of life: a report on two cases.
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao PauloMotor phenotyping in a Greek cohort of patients with neonatal and infantile onset developmental and epileptic encephalopathy.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology SocietyA frameshift variant in the SLC6A5 gene is associated with startle disease in a family of Old English Sheepdogs.
Animal geneticsRafiq Syndrome: Old Variant in MAN1B1 Gene and Some New Phenotypic Features.
Iranian journal of child neurologyMethylphenidate-Associated Hyperekplexia.
American journal of therapeuticsDPPX antibody-mediated disease mimicking Wernicke's encephalopathy.
BMJ case reportsNovel pathogenic variant in a mild case of type B molybdenum cofactor deficiency: case report and literature review.
BMC medical genomicsClinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephalitis: A Systematic Review.
Neurology(R) neuroimmunology & neuroinflammationNeonatal hyperekplexia: a non-epileptic paroxysmal movement disorder with a novel homozygous mutation in the GLRB gene, a seizure mimic.
BMJ case reportsAn Adult Case of Genetically Confirmed Hyperekplexia Presenting with Head Trauma.
NMC case report journalNeonatal Hyperekplexia: Is It Still a Diagnostic Challenge? Evidence From a Systematic Review.
Journal of child neurologyProgressive Encephalomyelitis With Rigidity and Myoclonus With Glycine Receptor and GAD65 Antibodies: Case Report and Potential Mechanisms.
Neurology(R) neuroimmunology & neuroinflammationHyperekplexia: A Single-Center Experience.
Journal of child neurologyRole of palmitoylation on the neuronal glycine transporter GlyT2.
Journal of neurochemistryHyperekplexia: Unveiling a Rare Neurological Condition With a Treatable Solution.
CureusThe One with Many Facets: Anti-Glycine Receptor Antibodies-Related Parkinsonism with Complex Visual Phenomena and Stiff-Limb Syndrome.
Movement disorders clinical practice[Clinical and genetic analysis of three children with Hyperekplexia].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsNeuropsychiatric Presentation of Anti-DPPX Progressive Encephalomyelitis with Rigidity and Myoclonus.
Movement disorders clinical practiceGain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes.
Brain : a journal of neurologyGeneralized Stiffness in Hereditary Hyperekplexia Responsive to Trihexyphenidyl: A Novel Finding.
Clinical pediatricsSymptomatic hyperekplexia: an important clue to neurodegeneration in children.
BMJ case reportsStiff Person Spectrum Disorders-An Update and Outlook on Clinical, Pathophysiological and Treatment Perspectives.
BiomedicinesNeonatal developmental and epileptic encephalopathy with movement disorders and arthrogryposis: A case report with a novel missense variant of SCN1A.
Brain & developmentHyperekplexia: A Treatable Seizure Mimicker in Infants.
CureusA loss-of-function variant in canine GLRA1 associates with a neurological disorder resembling human hyperekplexia.
Human geneticsA novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia.
Amyotrophic lateral sclerosis & frontotemporal degenerationThe c.126C>A(p.(Cys42Ter)) SLC7A10 nonsense variant is a candidate causative variant for paradoxical pseudomyotonia in English Cocker and Springer Spaniels.
Animal geneticsClinical and Neurophysiologic Phenotypes in Neonates With BRAT1 Encephalopathy.
NeurologyMyoclonus status revealing COVID 19 infection.
SeizureFour Turkish families with hyperekplexia: A missense mutation and the exon 1-7 deletion in the GLRA1 gene.
Parkinsonism & related disordersStartle Disease: An Overlooked Symptom of CTNNB1-Related Neurodevelopmental Disorder With Spastic Diplegia and Visual Defects.
Neurology. GeneticsAnti-glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus initially presenting with one-sided stiff face: A case report.
Frontiers in neurologyMyoclonus and other jerky movement disorders.
Clinical neurophysiology practiceHyperekplexia with congenital heart disease: anesthetic concerns and management.
Anesthesia and pain medicineHereditary Hyperekplexia in Saudi Arabia.
Pediatric neurologyExploring the Conformational Impact of Glycine Receptor TM1-2 Mutations Through Coarse-Grained Analysis and Atomistic Simulations.
Frontiers in molecular biosciencesHereditary Hyperekplexia: A New Family and a Systematic Review of GLRA1 Gene-Related Phenotypes.
Pediatric neurologyNociception in the Glycine Receptor Deficient Mutant Mouse Spastic.
Frontiers in molecular neuroscienceFacial Palsy as Initial Symptom in Glycine Receptor Antibody Positive Progressive Encephalomyelitis With Rigidity and Myoclonus: A Case Report.
Frontiers in neurologyClinical, genetic, and functional characterization of the glycine receptor β-subunit A455P variant in a family affected by hyperekplexia syndrome.
The Journal of biological chemistryHyperekplexia: A Frequent Near Miss in Infants and Young Children.
Neurology IndiaAnesthetic Management of an Adult With Hyperekplexia Undergoing a Laparoscopic Colectomy: A Case Report.
A&A practiceResearch Progress in the Study of Startle Reflex to Disease States.
Neuropsychiatric disease and treatmentIdentification of a stereotypic molecular arrangement of endogenous glycine receptors at spinal cord synapses.
eLifeSLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.
Human geneticsUnique Severe HyperEkplexia-Like Apneic Events (SHELAE) Improved by High-Dose Piracetam.
Child neurology openThe presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
Communications biologyNovel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle Disease.
Frontiers in molecular neuroscienceEpilepsy and BRAF Mutations: Phenotypes, Natural History and Genotype-Phenotype Correlations.
GenesDifferent Behaviors of a Glycine Receptor Channel Pore Residue between Wild-Type-Mimicking and Disease-Type-Mimicking Formats.
ACS chemical neuroscienceAutoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises.
Journal of neuroimmunologyAdvances in hyperekplexia and other startle syndromes.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyCase Report: Dexmedetomidine for Intractable Clusters of Myoclonic Jerks and Paroxysmal Sympathetic Hyperactivity in Progressive Encephalomyelitis With Rigidity and Myoclonus.
Frontiers in neurologyTeaching Video NeuroImage: Hereditary Hyperekplexia Mimicking Tonic Seizures in an Infant.
NeurologyDelivery of trans-membrane proteins by liposomes; the effect of liposome size and formulation technique on the efficiency of protein delivery.
International journal of pharmaceuticsA proline-rich motif in the large intracellular loop of the glycine receptor α1 subunit interacts with the Pleckstrin homology domain of collybistin.
Journal of advanced researchRescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
NeuropharmacologyCalcium-Dependent Regulation of the Neuronal Glycine Transporter GlyT2 by M2 Muscarinic Acetylcholine Receptors.
Neurochemical researchIliopsoas Hematomas in a Patient with Progressive Encephalomyelitis with Rigidity and Myoclonus.
Internal medicine (Tokyo, Japan)Rare cause of xanthinuria: a pediatric case of molybdenum cofactor deficiency B.
CEN case reportsAbnormal neurodevelopment outcome in case of neonatal hyperekplexia secondary to missense mutation in GLRB gene.
BMJ case reportsSubunit-Specific Photocontrol of Glycine Receptors by Azobenzene-Nitrazepam Photoswitcher.
eNeuroA System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors.
BiomoleculesCongenital immobility and stiffness related to biallelic ATAD1 variants.
Neurology. GeneticsCase report of a PRDM5 linked brittle cornea syndrome type 2 in association with a novel SLC6A5 mutation.
Indian journal of ophthalmologyPair of Residue Substitutions at the Outer Mouth of the Channel Pore Act as Inputs for a Boolean Logic "OR" Gate Based on the Glycine Receptor.
ACS chemical neuroscienceA new family with GLRB-related hyperekplexia showing chorea in homo- and heterozygous variant carriers.
Parkinsonism & related disordersAnxiety and Startle Phenotypes in Glrb Spastic and Glra1 Spasmodic Mouse Mutants.
Frontiers in molecular neuroscienceCharged residues at the pore extracellular half of the glycine receptor facilitate channel gating: a potential role played by electrostatic repulsion.
The Journal of physiologyHyperekplexia and other startle syndromes.
Journal of the neurological sciencesGlyT1 encephalopathy: Characterization of presumably disease causing GlyT1 mutations.
Neurochemistry internationalNeurobiology of glycine transporters: From molecules to behavior.
Neuroscience and biobehavioral reviewsHyperekplexia: a surprise diagnosis.
Neurologia i neurochirurgia polskaLigand-gated ion channels in genetic disorders and the question of efficacy.
The international journal of biochemistry & cell biologyThe Head Retraction Reflex in Niemann-Pick Type C: A Novel Diagnostic Clue.
Movement disorders clinical practiceTop of Basilar Syndrome Presenting With Hyperekplexia Initially Diagnosed as a Convulsive Status Epilepticus.
The Journal of emergency medicineThe startle disease mutation α1S270T predicts shortening of glycinergic synaptic currents.
The Journal of physiologyThe GRIA3 c.2477G > A Variant Causes an Exaggerated Startle Reflex, Chorea, and Multifocal Myoclonus.
Movement disorders : official journal of the Movement Disorder SocietyA Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition.
The Journal of neuroscience : the official journal of the Society for NeuroscienceC.292G>A, a novel glycine receptor alpha 1 subunit gene (GLRA1) mutation found in a Chinese patient with hyperekplexia: A case report.
MedicineApproach to exaggerated startle reflex: a case of hyperekplexia minor.
BMJ case reportsExcessive Startle with Novel GLRA1 Mutations in 4 Chinese Patients and a Literature Review of GLRA1-Related Hyperekplexia.
Journal of clinical neurology (Seoul, Korea)Ataxia telangiectasia like disorder: Another dopa-responsive disorder look-alike?
Parkinsonism & related disordersModulation of glycine receptor single-channel conductance by intracellular phosphorylation.
Scientific reportsClinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies.
Neurology(R) neuroimmunology & neuroinflammationA Case of Hyperekplexia That Started From Childhood: Clinical Diagnosis With Negative Genetic Investigations.
Frontiers in neurologyNot every excessive startle is hyperekplexia, the curious case of SOD1.
Brain : a journal of neurologyThe synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABAA receptor isoform in a cell model of hyperekplexia.
The Journal of biological chemistryA Refined Open State of the Glycine Receptor Obtained via Molecular Dynamics Simulations.
Structure (London, England : 1993)Creutzfeldt-Jakob disease presenting with encephalopathy, rigidity, and hyperekplexia.
Neurology. Clinical practiceA Preschooler Girl With Hyperekplexia Treated With Escitalopram.
Clinical neuropharmacologyE3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
Scientific reportsNovel mutations in SLC6A5 with benign course in hyperekplexia.
Cold Spring Harbor molecular case studiesNomenclature of Genetically Determined Myoclonus Syndromes: Recommendations of the International Parkinson and Movement Disorder Society Task Force.
Movement disorders : official journal of the Movement Disorder SocietyThe Beneficence of Cuddle Therapy in Hyperekplexia: A Case Report.
Advances in neonatal care : official journal of the National Association of Neonatal NursesHijacking of GABAA Receptors by Mutant Glycine Receptors.
Trends in molecular medicineHuman Hyperekplexic Mutations in Glycine Receptors Disinhibit the Brainstem by Hijacking GABAA Receptors.
iScienceImpaired glycinergic transmission in hyperekplexia: a model of parasomnia overlap disorder.
Annals of clinical and translational neurologyThe P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia.
The European journal of neuroscienceSOD1 deficiency: a novel syndrome distinct from amyotrophic lateral sclerosis.
Brain : a journal of neurologyMolecular Specialization of GABAergic Synapses on the Soma and Axon in Cortical and Hippocampal Circuit Function and Dysfunction.
Frontiers in molecular neuroscienceSpecial issue on canine genetics: animal models for human disease and gene therapies, new discoveries for canine inherited diseases, and standards and guidelines for clinical genetic testing for domestic dogs.
Human geneticsIndividual knock out of glycine receptor alpha subunits identifies a specific requirement of glra1 for motor function in zebrafish.
PloS oneInhibitory Actions of Tropeines on the α3 Glycine Receptor Function.
Frontiers in pharmacologyTeaching Video NeuroImages: Cautious walking gait in siblings with hereditary hyperekplexia.
NeurologyCurrent Overview of Neonatal Convulsions.
Sisli Etfal Hastanesi tip bulteniRescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.
NeuropharmacologyThe role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain-of-function mutation.
The Journal of physiologyClinical features and genetic analysis of two siblings with startle disease in an Italian family: a case report.
BMC medical geneticsMovement disorders in early MS and related diseases: A prospective observational study.
Neurology. Clinical practiceA glycine transporter SLC6A5 frameshift mutation causes startle disease in Spanish greyhounds.
Human geneticsLeucine-485 deletion variant of BRAF may exhibit the severe end of the clinical spectrum of CFC syndrome.
Journal of human genetics[Pathophysiology of the glutamate and the glycine transporters: new therapeutic targets].
Revista de neurologiaA case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon.
BMC neurologyCharacterization of the Zebrafish Glycine Receptor Family Reveals Insights Into Glycine Receptor Structure Function and Stoichiometry.
Frontiers in molecular neuroscienceModification of a Putative Third Sodium Site in the Glycine Transporter GlyT2 Influences the Chloride Dependence of Substrate Transport.
Frontiers in molecular neuroscienceThe postnatal development of ultrasonic vocalization-associated breathing is altered in glycine transporter 2-deficient mice.
The Journal of physiology[Non-epileptic paroxysmal disorder in neonates].
MedicinaA novel nonsense autosomal dominant mutation in the GLRA1 gene causing hyperekplexia.
Journal of neural transmission (Vienna, Austria : 1996)GLRA1 mutation and long-term follow-up of the first hyperekplexia family.
Neurology. GeneticsA child with hyperekplexia and epileptic myoclonus.
Epileptic disorders : international epilepsy journal with videotapeNeonatal tremor episodes and hyperekplexia-like presentation at onset in a child with SCN8A developmental and epileptic encephalopathy.
Epileptic disorders : international epilepsy journal with videotape[A pedigree of hereditary hyperekplexia].
Rinsho shinkeigaku = Clinical neurologySeizures in 3-month-old infant when placed on stomach.
Journal of paediatrics and child healthHyperekplexia-associated mutations in the neuronal glycine transporter 2.
Neurochemistry internationalExpanding the phenotype of TRAK1 mutations: hyperekplexia and refractory status epilepticus.
Brain : a journal of neurologyNose-tapping Test in Hyperekplexia.
Indian pediatricsWeird Laughing in Hyperekplexia: A new phenotype associated with a novel mutation in the GLRA1 gene?
SeizureStartles, Stiffness, and SLC6A5: Do You Know the Condition?
Pediatric neurologyGlycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.
Neurology(R) neuroimmunology & neuroinflammationStructure/Function Studies of the α4 Subunit Reveal Evolutionary Loss of a GlyR Subtype Involved in Startle and Escape Responses.
Frontiers in molecular neuroscienceA Missense Mutation A384P Associated with Human Hyperekplexia Reveals a Desensitization Site of Glycine Receptors.
The Journal of neuroscience : the official journal of the Society for NeuroscienceCharacterization of a novel variant in siblings with Asparagine Synthetase Deficiency.
Molecular genetics and metabolismMutations affecting glycinergic neurotransmission in hyperekplexia increase pain sensitivity.
Brain : a journal of neurologySLC6 Transporter Folding Diseases and Pharmacochaperoning.
Handbook of experimental pharmacologySporadic hyperekplexia due to self-limiting brainstem encephalopathy.
Neuropsychiatric disease and treatmentMovement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.
Brain : a journal of neurologyA novel compound mutation in GLRA1 cause hyperekplexia in a Chinese boy- a case report and review of the literature.
BMC medical geneticsCACNA1A-related early-onset encephalopathy with myoclonic epilepsy: A case report.
Brain & developmentHyperekplexia: A forgotten diagnosis clinched by next-generation sequencing.
Neurology India[Myoclonus as a movement disorder].
Der NervenarztP2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2.
NeuropharmacologyDisruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease.
The Journal of neuroscience : the official journal of the Society for NeuroscienceA scoring system predicting the clinical course of CLPB defect based on the foetal and neonatal presentation of 31 patients.
Journal of inherited metabolic diseaseThe phenotypic spectrum of ARHGEF9 includes intellectual disability, focal epilepsy and febrile seizures.
Journal of neurologyFrom dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
Journal of neuroimmunologyClinical and Electrophysiological Findings in Two Siblings with Familial Hyperekplexia.
Noro psikiyatri arsiviSporadic Hyperekplexia Plus Syndrome.
Journal of pediatric neurosciencesGlycine Receptor Drug Discovery.
Advances in pharmacology (San Diego, Calif.)Cataplexy and Its Mimics: Clinical Recognition and Management.
Current treatment options in neurologyThe role of charged residues in independent glycine receptor folding domains for intermolecular interactions and ion channel function.
Journal of neurochemistryTeaching Video NeuroImages: Hyperekplexia: A syndrome of pathologic startle responses.
NeurologyDPPX antibody-associated encephalitis: Main syndrome and antibody effects.
NeurologyThe Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site.
The Journal of biological chemistry[Clinical and genetic analysis of hyperekplexia in a Chinese child and literature review].
Zhonghua er ke za zhi = Chinese journal of pediatricsGLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder.
Molecular psychiatryFamilial Hyperekplexia, a Potential Cause of Cautious Gait: A New Korean Case and a Systematic Review of Phenotypes.
Journal of movement disordersVisually evoked startle response in a patient with epilepsy: a case report and review of the literature.
NeurocaseGlycinergic transmission: glycine transporter GlyT2 in neuronal pathologies.
Neuronal signalingHyperekplexia: Report on phenotype and genotype of 16 Jordanian patients.
Brain & developmentLoss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.
American journal of human geneticsThe astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.
Scientific reports[Autoimmune encephalitis due to mantle cell lymphoma].
Nederlands tijdschrift voor geneeskundeThe Free Zinc Concentration in the Synaptic Cleft of Artificial Glycinergic Synapses Rises to At least 1 μM.
Frontiers in molecular neuroscienceDiaphragmatic Eventration in Sisters with Asparagine Synthetase Deficiency: A Novel Homozygous ASNS Mutation and Expanded Phenotype.
JIMD reportsDefects of the Glycinergic Synapse in Zebrafish.
Frontiers in molecular neuroscienceHyperekplexia, microcephaly and simplified gyral pattern caused by novel ASNS mutations, case report.
BMC neurologySynaptopathies: synaptic dysfunction in neurological disorders - A review from students to students.
Journal of neurochemistryXq11.1-11.2 deletion involving ARHGEF9 in a girl with autism spectrum disorder.
European journal of medical geneticsInvestigating the Mechanism by Which Gain-of-function Mutations to the α1 Glycine Receptor Cause Hyperekplexia.
The Journal of biological chemistryMurine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.
The Journal of physiologyA de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.
BMC neurologyPresynaptic facilitation of glycinergic mIPSC is reduced in mice lacking α3 glycine receptor subunits.
NeuroscienceAsc-1 Transporter Regulation of Synaptic Activity via the Tonic Release of d-Serine in the Forebrain.
Cerebral cortex (New York, N.Y. : 1991)The Diagnosis and Treatment of Autoimmune Encephalitis.
Journal of clinical neurology (Seoul, Korea)Disturbances of Ligand Potency and Enhanced Degradation of the Human Glycine Receptor at Affected Positions G160 and T162 Originally Identified in Patients Suffering from Hyperekplexia.
Frontiers in molecular neuroscienceTSEN54 gene-related pontocerebellar hypoplasia type 2 presenting with exaggerated startle response: report of two cases in a family.
The Turkish journal of pediatricsHyperekplexia as the presenting symptom of Creutzfeldt-Jakob disease.
Neurology. Clinical practiceGlycine receptor mechanism elucidated by electron cryo-microscopy.
Nature[Hyperekplexia associated to precocious puberty].
Revista de neurologiaAnesthetic management of a parturient with hyperekplexia.
A & A case reportsThe alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission.
EMBO reportsRapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome may have a hypothalamus-periaqueductal gray localization.
Pediatric neurologyAllosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure.
Proceedings of the National Academy of Sciences of the United States of AmericaAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Hiperecplexia.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Hiperecplexia
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- A case of childhood hyperekplexia due to a novel nonsense variant in the GLRA1 gene.
- A Novel Variant in GLRA1 Associated With Emotional Stimulus-Sensitive Hemichoreic Movements.
- A New GlyT2 Variant Associated with Hyperekplexia.
- Motor phenotyping in a Greek cohort of patients with neonatal and infantile onset developmental and epileptic encephalopathy.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society· 2025· PMID 40068485mais citado
- Rafiq Syndrome: Old Variant in MAN1B1 Gene and Some New Phenotypic Features.
- Role of the Glycine Transporter GlyT2 in the Neuronal Differentiation of PC12 Cells.
- A dual manifestation of GAD-antibody spectrum disorder: a case of progressive encephalomyelitis with rigidity, myoclonus and autoimmune epilepsy with mesial temporal sclerosis.
- Asparagine Synthetase Deficiency.
- Clinical features of progressive encephalomyelitis with rigidity and myoclonus: Case Report.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:306773(Orphanet)
- MONDO:0017658(MONDO)
- GARD:21281(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q1781802(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
